期刊文献+

肝内胆管癌组织中PlGF的表达与MVD的关系 被引量:2

Relationship between the expression of PlGF and MVD in human intrahepatic cholangiocarcinoma
下载PDF
导出
摘要 目的研究肝内胆管癌(ICC)组织中PlGF的表达与微血管密度(MVD)的关系。方法通过免疫组织化学的方法检测50例肝内胆管癌及8例正常肝组织胆管上皮细胞胎盘生长因子(PlGF)的表达及MVD。结果 ICC组织PlGF阳性表达率、强阳性表达率分别为54%、28%,正常肝组织胆管上皮细胞PlGF阳性表达率、强阳性表达率分别为25%、0%,ICC组织MVD及正常肝组织MVD分别为52.88±21.40、14.86±3.38,ICC组织PlGF(+)、(++)表达率及MVD均显著高于正常肝内胆管上皮细胞(P<0.05)。胆管癌PlGF(++)组、PlGF(+)组及PlGF(-)组MVD分别为65.36±22.87、51.80±18.12、36.68±17.80,胆管癌PlGF(++)组MVD>PlGF(+)组MVD>PlGF(-)组MVD,差异具有统计学意义(P<0.05)。结论 PlGF在肝内胆管癌的发生、发展中起着一定的作用,尤其是在血管生成方面。 Objective To study the relationship between the PlGF expression and MVD in human intrahepatic cholangiocarcinoma(ICC).Methods The expression of PlGF and MVD were examined by immunohistochemistry in 50 human intrahepatic cholangiocarcinoma tissues and 8 normal liver tissues.Results The(+) and(++) expression rate of PlGF were 54% and 28% in ICC tissues,25% and 0% in biliary epithelium of the normal liver tissues,respectively.The MVD of ICC tissues and normal liver tissues were 52.88±21.40 and 14.86±3.38,respectively.The(+) and(++) expression rate of PlGF and MVD in ICC tissues were significantly higher than that in normal liver tissues(P〈0.05).The MVD of PlGF(++) group,PlGF(+) group,and PlGF(-) group were 65.36±22.87,51.80±18.12,and 36.68±17.80,respectively.The MVD of PlGF(++) group was higher than that of PlGF(+) group,MVD of PlGF(+) group was higher than that of PlGF(-) group,and the differences were significant(P〈0.05).Conclusion PlGF is related to ICC.The increased Plgf expression may be one of the factors that promote angiogenesis in human ICCs.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第12期1152-1154,F0002,共4页 Chongqing medicine
关键词 胆管 肝内 胆管肿瘤 胎盘生长因子 微血管密度 血管生成 bile ducts intrahepatic bile duct neoplasms PlGF MVD angiogenesis
  • 相关文献

参考文献18

  • 1Patel T.Increasing incidence and mortality of primary in-trahepatic cholangiocarcinoma in the United States[J].Hepatology,2001,33(6):1353-1357.
  • 2Taylor-Robinson SD,Toledano MB,Arora S,et al.In-crease in mortality rates from intrahepatic cholangiocarci-noma in England and Wales 1968-1998[J].Gut,2001,48(6):816-820.
  • 3Okuda K,Nakanuma Y,Miyazaki M.Cholangiocarcino-ma:recent progress.part 1:epidemiology and etiology[J].J Gastroenterol Hepatol,2002,17(10):1049-1055.
  • 4Jarnagin WR,Shoup M.Surgical management of cholan-giocarcinoma[J].Semin Liver Dis,2004,24(2):189-199.
  • 5Bernstein LR,Liotta LA.Molecular mediators of interac-tions with extracellular matrix components in metastasisand angiogenesis[J].Curr Opin Oncol,1994,6(1):106-113.
  • 6Folkman J.What is the evidence that tumors are angio-genesis dependent[J].J Natl Cancer Inst,1990,82(1):4-6.
  • 7Fischer C,Jonckx B,Mazzone M,et al.Anti-PIGF inhibitsgrowth of VEGF(R)-inhibitor-resistant tumors withoutaffecting healthy vessels[J].Cell,2007,131(3):463-475.
  • 8Fromowitz FB,Viola MV,Chao S,et al.Ras p21expres-sion in the progression of breast cancer[J].Hum Pathol,1987,18(12):1268-1275.
  • 9Weidner N.Intratumor microvessel density as a prognos-tic factor in cancer[J].Am J Pathol,1995,147(1):9-19.
  • 10Roskoski RJr.Vascular endothelial growth factor(VEGF)signaling in tumor progression[J].Crit Rev Oncol Hematol,2007,62(3):179-213.

同被引文献29

  • 1王瑞婷,申兴斌,张泓波.VEGF在大肠癌中的表达及意义[J].山东医药,2006,46(35):57-58. 被引量:7
  • 2冯树,宋今丹.大肠癌分化、浸润和转移与细胞外基质的关系[J].中国肿瘤临床,1997,24(2):100-103. 被引量:4
  • 3张涛,郭建平.血管内皮生长因子在大肠癌组织中的表达及其临床意义[J].中国医学工程,2007,15(7):570-573. 被引量:5
  • 4De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med, 2012,44(1):1-9.
  • 5Xu HX, Zhu XD, Zhuang PY, et al. Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue. Int J Cancer, 2010,128(7):1559.
  • 6Nagy JA, Dvorak AM, Dvorak HF. VEGF-A (164/165) and PlGF: Roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med, 2003,13(5):169-175.
  • 7Zhang L, Chen J, Ke Y, et al. Expression of placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol, 2005,3:68-79.
  • 8Taylor AP, Leon E, Goldenberg DM. Goldenberg, Placental growth factor (PLGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement. Br J Cancer, 2010,103(1):82-89.
  • 9徐华祥.胎盘生长因子在肝细胞肝癌和癌周肝组织中表达及其预后价值.上海:复旦大学,2010:27-29.
  • 10Nagaoka S, Yoshida T, Akiyoshi J, et al. The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma. Oncol Rep, 2010,23(6):1647-1654.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部